APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

β-Nicotinamide Mononucleotide (NMN)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global β-Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026

Report ID 173317590422 December 2025199 pages

Choose your research edition.

Industry Researchβ-Nicotinamide Mononucleotide (NMN) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal β-Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal β-Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal β-Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal β-Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global β-Nicotinamide Mononucleotide (NMN) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for β-Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for β-Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for β-Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the β-Nicotinamide Mononucleotide (NMN) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the β-Nicotinamide Mononucleotide (NMN) market include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global β-Nicotinamide Mononucleotide (NMN) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of β-Nicotinamide Mononucleotide (NMN) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents β-Nicotinamide Mononucleotide (NMN) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the β-Nicotinamide Mononucleotide (NMN) market size, projected growth trends, production technologies, key applications, and end-use industries.

β-Nicotinamide Mononucleotide (NMN) Segment by Company

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

β-Nicotinamide Mononucleotide (NMN) Segment by Content

Above 98%

Below 98%

β-Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

β-Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global β-Nicotinamide Mononucleotide (NMN) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions β-Nicotinamide Mononucleotide (NMN) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify β-Nicotinamide Mononucleotide (NMN) significant trends, drivers, influence factors in global and regions.

6. To analyze β-Nicotinamide Mononucleotide (NMN) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global β-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of β-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of β-Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the β-Nicotinamide Mononucleotide (NMN) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global β-Nicotinamide Mononucleotide (NMN) industry.

Chapter 3: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of β-Nicotinamide Mononucleotide (NMN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of β-Nicotinamide Mononucleotide (NMN) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. β-Nicotinamide Mononucleotide (NMN) Industry Trends Table 2. β-Nicotinamide Mononucleotide (NMN) Industry Drivers Table 3. β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges Table 4. β-Nicotinamide Mononucleotide (NMN) Industry Restraints Table 5. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Company (2021-2026) Table 7. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Company (Kg) & (2021-2026) Table 8. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Company (2021-2026) Table 9. Global β-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Company (2021-2026) Table 10. Global β-Nicotinamide Mononucleotide (NMN) Company Ranking, (2024-2026) & (USD Million) Table 11. Global β-Nicotinamide Mononucleotide (NMN) Key Company Manufacturing Base & Headquarters Table 12. Global β-Nicotinamide Mononucleotide (NMN) Company, Product Type & Application Table 13. Global β-Nicotinamide Mononucleotide (NMN) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global β-Nicotinamide Mononucleotide (NMN) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Above 98% Table 18. Significant Companies of Below 98% Table 19. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021-2026) & (Kg) Table 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2027-2032) & (Kg) Table 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Type (2021-2026) Table 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Type (2027-2032) Table 24. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type (2021-2026) Table 28. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Health Care Products Table 30. Significant Companies of Cosmetics Table 31. Significant Companies of Others Table 32. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021-2026) & (Kg) Table 34. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2027-2032) & (Kg) Table 35. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Application (2021-2026) Table 36. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Application (2027-2032) Table 37. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application (2021-2026) Table 41. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application (2027-2032) Table 42. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg) Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026) Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032) & (Kg) Table 46. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2027-2032) Table 47. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Region (2021-2026) Table 50. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Region (2027-2032) Table 52. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2021-2026) Table 53. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2027-2032) Table 54. Global β-Nicotinamide Mononucleotide (NMN) Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2021-2026) Table 58. Global β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 59. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2027-2032) Table 60. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Country (2021-2026) Table 62. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Country (2027-2032) Table 64. GeneHarbor Company Information Table 65. GeneHarbor Business Overview Table 66. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 67. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 68. GeneHarbor Recent Development Table 69. Herbalmax Company Information Table 70. Herbalmax Business Overview Table 71. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 72. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 73. Herbalmax Recent Development Table 74. Genex Formulas Company Information Table 75. Genex Formulas Business Overview Table 76. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 77. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 78. Genex Formulas Recent Development Table 79. Shinkowa Pharmaceutical Company Information Table 80. Shinkowa Pharmaceutical Business Overview Table 81. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 82. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 83. Shinkowa Pharmaceutical Recent Development Table 84. Maac10 Formulas Company Information Table 85. Maac10 Formulas Business Overview Table 86. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 87. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 88. Maac10 Formulas Recent Development Table 89. EffePharm Company Information Table 90. EffePharm Business Overview Table 91. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 92. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 93. EffePharm Recent Development Table 94. Bontac Company Information Table 95. Bontac Business Overview Table 96. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 97. Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 98. Bontac Recent Development Table 99. CELFULL Company Information Table 100. CELFULL Business Overview Table 101. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 102. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 103. CELFULL Recent Development Table 104. Kingdomway Company Information Table 105. Kingdomway Business Overview Table 106. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 107. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio Table 108. Kingdomway Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. β-Nicotinamide Mononucleotide (NMN) Distributors List Table 112. β-Nicotinamide Mononucleotide (NMN) Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Image Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 4. Global β-Nicotinamide Mononucleotide (NMN) Sales (2021-2032) & (Kg) Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Above 98% Image Figure 10. Below 98% Image Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Type (2021-2032) Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type (2021-2032) Figure 17. Health Care Products Image Figure 18. Cosmetics Image Figure 19. Others Image Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Application (2021-2032) Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application (2021-2032) Figure 26. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 31. North America β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 37. South America β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. β-Nicotinamide Mononucleotide (NMN) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. β-Nicotinamide Mononucleotide (NMN) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Above 98%
  • Below 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • Shinkowa Pharmaceutical
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  4. 1.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume (2021-2032)
  5. 1.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 β-Nicotinamide Mononucleotide (NMN) Market Dynamics
  1. 2.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 2.2 β-Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 2.3 β-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 2.4 β-Nicotinamide Mononucleotide (NMN) Industry Restraints
3 β-Nicotinamide Mononucleotide (NMN) Market by Company
  1. 3.1 Global β-Nicotinamide Mononucleotide (NMN) Company Revenue Ranking in 2025
  2. 3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2021-2026)
  3. 3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Company (2021-2026)
  4. 3.4 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Company (2021-2026)
  5. 3.5 Global β-Nicotinamide Mononucleotide (NMN) Company Ranking (2024-2026)
  6. 3.6 Global β-Nicotinamide Mononucleotide (NMN) Company Manufacturing Base and Headquarters
  7. 3.7 Global β-Nicotinamide Mononucleotide (NMN) Company Product Type and Application
  8. 3.8 Global β-Nicotinamide Mononucleotide (NMN) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global β-Nicotinamide Mononucleotide (NMN) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 β-Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 β-Nicotinamide Mononucleotide (NMN) Market by Type
  1. 4.1 β-Nicotinamide Mononucleotide (NMN) Type Introduction
  2. 4.1.1 Above 98%
  3. 4.1.2 Below 98%
  4. 4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type
  5. 4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type
  9. 4.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021-2032)
  11. 4.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type (2021-2032)
5 β-Nicotinamide Mononucleotide (NMN) Market by Application
  1. 5.1 β-Nicotinamide Mononucleotide (NMN) Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 Cosmetics
  4. 5.1.3 Others
  5. 5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application
  6. 5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application
  10. 5.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021-2032)
  12. 5.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application (2021-2032)
6 β-Nicotinamide Mononucleotide (NMN) Regional Sales and Value Analysis
  1. 6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2032)
  3. 6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region: 2021-2026
  4. 6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032)
  5. 6.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2021-2032)
  7. 6.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2021-2026
  8. 6.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2027-2032)
  9. 6.5 Global β-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  12. 6.6.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  15. 6.7.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  21. 6.9.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Country, 2025 VS 2032
7 β-Nicotinamide Mononucleotide (NMN) Country-level Sales and Value Analysis
  1. 7.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2032)
  4. 7.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
  5. 7.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032)
  6. 7.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (2021-2032)
  7. 7.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (2021-2026)
  8. 7.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt β-Nicotinamide Mononucleotide (NMN) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GeneHarbor
  2. 8.1.1 GeneHarbor Company Information
  3. 8.1.2 GeneHarbor Business Overview
  4. 8.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  6. 8.1.5 GeneHarbor Recent Developments
  7. 8.2 Herbalmax
  8. 8.2.1 Herbalmax Company Information
  9. 8.2.2 Herbalmax Business Overview
  10. 8.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  12. 8.2.5 Herbalmax Recent Developments
  13. 8.3 Genex Formulas
  14. 8.3.1 Genex Formulas Company Information
  15. 8.3.2 Genex Formulas Business Overview
  16. 8.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  18. 8.3.5 Genex Formulas Recent Developments
  19. 8.4 Shinkowa Pharmaceutical
  20. 8.4.1 Shinkowa Pharmaceutical Company Information
  21. 8.4.2 Shinkowa Pharmaceutical Business Overview
  22. 8.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  24. 8.4.5 Shinkowa Pharmaceutical Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 EffePharm
  32. 8.6.1 EffePharm Company Information
  33. 8.6.2 EffePharm Business Overview
  34. 8.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  36. 8.6.5 EffePharm Recent Developments
  37. 8.7 Bontac
  38. 8.7.1 Bontac Company Information
  39. 8.7.2 Bontac Business Overview
  40. 8.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  42. 8.7.5 Bontac Recent Developments
  43. 8.8 CELFULL
  44. 8.8.1 CELFULL Company Information
  45. 8.8.2 CELFULL Business Overview
  46. 8.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  48. 8.8.5 CELFULL Recent Developments
  49. 8.9 Kingdomway
  50. 8.9.1 Kingdomway Company Information
  51. 8.9.2 Kingdomway Business Overview
  52. 8.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio
  54. 8.9.5 Kingdomway Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 β-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 9.1.1 β-Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 β-Nicotinamide Mononucleotide (NMN) Sales Mode & Process
  6. 9.2 β-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 β-Nicotinamide Mononucleotide (NMN) Distributors
  9. 9.2.3 β-Nicotinamide Mononucleotide (NMN) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst